Eric

And also, we may be treating you, like, for example, with an anti-inflammatory drug or, you know, we can talk in some of the specifics. But we've had breakthroughs, Mel. Like, for example, Alzheimer's. There's a blood test now called P-Tau-217. It's as good as having a PET scan of for telling us, are we going to have a risk for Alzheimer's?

And also, we may be treating you, like, for example, with an anti-inflammatory drug or, you know, we can talk in some of the specifics. But we've had breakthroughs, Mel. Like, for example, Alzheimer's. There's a blood test now called P-Tau-217. It's as good as having a PET scan of for telling us, are we going to have a risk for Alzheimer's?

And also, we may be treating you, like, for example, with an anti-inflammatory drug or, you know, we can talk in some of the specifics. But we've had breakthroughs, Mel. Like, for example, Alzheimer's. There's a blood test now called P-Tau-217. It's as good as having a PET scan of for telling us, are we going to have a risk for Alzheimer's?

So if you get that test, again, if you have Alzheimer's in your family, it's not good enough to know, oh, I'm at risk for Alzheimer's, but I may only crop up when I'm 95. That's not really important. What we're going to have with multimodal AI is going to say you're at risk for Alzheimer's.

So if you get that test, again, if you have Alzheimer's in your family, it's not good enough to know, oh, I'm at risk for Alzheimer's, but I may only crop up when I'm 95. That's not really important. What we're going to have with multimodal AI is going to say you're at risk for Alzheimer's.

So if you get that test, again, if you have Alzheimer's in your family, it's not good enough to know, oh, I'm at risk for Alzheimer's, but I may only crop up when I'm 95. That's not really important. What we're going to have with multimodal AI is going to say you're at risk for Alzheimer's.

And if you don't do anything about it at age 66 is when you're going to see, you know, mild cognitive impairment. So you can actually pinpoint the person and the time.

And if you don't do anything about it at age 66 is when you're going to see, you know, mild cognitive impairment. So you can actually pinpoint the person and the time.

And if you don't do anything about it at age 66 is when you're going to see, you know, mild cognitive impairment. So you can actually pinpoint the person and the time.

You got it. I mean, this is why we have the benefits of that long time to work with before the person gets the condition. And we have the layers of data which we didn't have before or the ability to analyze that. And then the surveillance tools, whether it's scans or whether it's... Further blood tests, clocks. Like, you know what?

You got it. I mean, this is why we have the benefits of that long time to work with before the person gets the condition. And we have the layers of data which we didn't have before or the ability to analyze that. And then the surveillance tools, whether it's scans or whether it's... Further blood tests, clocks. Like, you know what?

You got it. I mean, this is why we have the benefits of that long time to work with before the person gets the condition. And we have the layers of data which we didn't have before or the ability to analyze that. And then the surveillance tools, whether it's scans or whether it's... Further blood tests, clocks. Like, you know what?

If I have an organ clock that says that my heart is accelerated aging and then I do these things and I prove, oh, wow, I changed it. It's now going in the other direction. Wow. And it reinforces that you're on the right track. So this is where we're headed now. The science of aging has given us these metrics, whether it's this body-wide aging, epigenetic clock, organ aging.

If I have an organ clock that says that my heart is accelerated aging and then I do these things and I prove, oh, wow, I changed it. It's now going in the other direction. Wow. And it reinforces that you're on the right track. So this is where we're headed now. The science of aging has given us these metrics, whether it's this body-wide aging, epigenetic clock, organ aging.

If I have an organ clock that says that my heart is accelerated aging and then I do these things and I prove, oh, wow, I changed it. It's now going in the other direction. Wow. And it reinforces that you're on the right track. So this is where we're headed now. The science of aging has given us these metrics, whether it's this body-wide aging, epigenetic clock, organ aging.

This is the most amazing thing. All these years of practicing medicine, we keep talking about prevention. And we have nothing that we're preventing. It's secondary prevention. Oh, you had a heart attack? Now we're going to put you on this and that. We are talking now about primary prevention. That's the new thing here, that we can prevent a disease that was going to occur before it happens.

This is the most amazing thing. All these years of practicing medicine, we keep talking about prevention. And we have nothing that we're preventing. It's secondary prevention. Oh, you had a heart attack? Now we're going to put you on this and that. We are talking now about primary prevention. That's the new thing here, that we can prevent a disease that was going to occur before it happens.

This is the most amazing thing. All these years of practicing medicine, we keep talking about prevention. And we have nothing that we're preventing. It's secondary prevention. Oh, you had a heart attack? Now we're going to put you on this and that. We are talking now about primary prevention. That's the new thing here, that we can prevent a disease that was going to occur before it happens.

And that's the real deal, prevention.

And that's the real deal, prevention.